Member Info for Jco252

in both also greg , hoping for the same obviously lol

karl , likewise i hope all can make a bit out of aim , i also topped up this week in my sipp where most my holdings are , which for me is a medium term trade, as maninpink said , could be 6 months could be 6 years but i am happy with my holdings , intra day price movement doesnt detract from my overall expectations and if it does reach my goal sooner then happy days ,if not ill wait it out ,

have a good day all

my thoughts mary, price sensitive

being a novice , what happens to the shares if they delist and later relist ?

thank you arps, ill be sitting on my hands and await later news

in the back of my mind , as always with gdr, is there going to be a sucker punch and a raise? not being negative as i am a holder and have been for some time, but its a nagging thought !

just had a look and noticed we slightly up , is it on the back of NYCT up 37% ?

praying for her speedy recovery Kate x

i hope Foch get there teeth into this as per news reports last week

what a t****** tom is , he orchestrated this , 30pieces of silver tom was it worth it ?

no but michelle mone wants to lol

i hope she does rocket , im still long in single pence , bubble !

this was from google lol!
List Of Market Maker Signals
1. 100 - I need Shares.
2. 200 - I need Shares badly but do not take the stock down.
3. 300 - Take (or I am taking) the stock down at least 30% so I can load shares.
4. 400 - Keep trading it sideways.
5. 500 - Gap the stock. Gap can be up or down, depending on direction of 500 signal.
6. 505 - I am short on shares
7. 600 - Apply resistance at the ASK to keep the price from increasing.
8. 700 - Move the price up.
9. 777 - Also recognized as a signal to move the price up.
10. 800 - Prepare for an increase in trading volume.
11. 900 - Allow the stock to float and trade freely.
12. 911 - Pending News/Press Release On The Way
13. 1000 - Don't let it run
14. 2100 - Let it run

1 and 11 trades , whats the theory mate if you dont mind me asking

yeh i see something similar on twitter about this , Foschini unhappy with interpath , but of course interpath would never do anything untoward , everything by the book with crook tom lol!

one things is for certain pumpy , no ramper / deramper will ever influence me either buying or selling this or any other share , that is why research is paramount imo !

dsaf , i agree that the pricing makes this only for a select customer base and if they are going to crack a different finacial bracket then they need to look at this , but they cannot compromise on quality over quantity .

earlier this year i did a comparison on 3 tests , the york test , nebraska test and the omega test , asked my gp ( who is my brother in law ) to assess the results . in his conclusion the other 2 we like comparing a ford fiesta to a bentley ! , yes they are tests but the differentiator in his opinion was the comprehensive test results, point of care clinic detective and the scientific nature of the tests . now obviously there is a price difference and that is where your paying for the bentley !

not to knock the other tests because they were "fine", but it when it comes to my health i personally dont want "fine/ok " i would prefer , and i have no doubt you would also , to have the best available .

dyor

dsaf i agree that they are not very forthcomimg with info about revenue and have emailed the co about this as it does need to be more transparent and what constitutes substantial

Absolutely, still no SALES RNS to a single lab.. or for a single product to leave the premises.

dsaf , would be so kind to enlighten me on where the revenue is coming from if the company doesnt actually sell anything as you say ?